BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28841204)

  • 1. From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation.
    Jiménez C; Alonso-Álvarez S; Alcoceba M; Ordóñez GR; García-Álvarez M; Prieto-Conde MI; Chillón MC; Balanzategui A; Corral R; Marín LA; Gutiérrez NC; Puig N; Sarasquete ME; González M; García-Sanz R
    Blood Cancer J; 2017 Aug; 7(8):e591. PubMed ID: 28841204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
    Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
    Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare transformation to double hit lymphoma in Waldenstrom's macroglobulinemia.
    Okolo ON; Johnson AC; Yun S; Arnold SJ; Anwer F
    Immunotherapy; 2017 Aug; 9(9):709-714. PubMed ID: 28771100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.
    Zheng M; Perry AM; Bierman P; Loberiza F; Nasr MR; Szwajcer D; Del Bigio MR; Smith LM; Zhang W; Greiner TC
    Neuropathology; 2017 Dec; 37(6):509-516. PubMed ID: 28856744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma.
    Manso BA; Wenzl K; Asmann YW; Maurer MJ; Manske M; Yang ZZ; Slager SL; Nowakowski GS; Ansell SM; Witzig TE; Feldman AL; Rimsza L; Link B; Cerhan JR; Novak AJ
    Blood Cancer J; 2017 Apr; 7(4):e553. PubMed ID: 28430174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88
    Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y
    Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.
    Frick M; Bettstetter M; Bertz S; Schwarz-Furlan S; Hartmann A; Richter T; Lenze D; Hummel M; Dreyling M; Lenz G; Gaumann A
    Leuk Lymphoma; 2018 May; 59(5):1260-1263. PubMed ID: 28868954
    [No Abstract]   [Full Text] [Related]  

  • 9. Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells.
    Sewastianik T; Guerrera ML; Adler K; Dennis PS; Wright K; Shanmugam V; Huang Y; Tanton H; Jiang M; Kofides A; Demos MG; Dalgarno A; Patel NA; Nag A; Pinkus GS; Yang G; Hunter ZR; Jarolim P; Munshi NC; Treon SP; Carrasco RD
    Blood Adv; 2019 Nov; 3(21):3360-3374. PubMed ID: 31698464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Relationship and Mutation Analysis in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia Associated With Diffuse Large B-cell Lymphoma.
    Berendsen MR; van Bladel DAG; Hesius E; Berganza Irusquieta C; Rijntjes J; van Spriel AB; van der Spek E; Pruijt JFM; Kroeze LI; Hebeda KM; Croockewit S; Stevens WBC; van Krieken JHJM; Groenen PJTA; van den Brand M; Scheijen B
    Hemasphere; 2023 Nov; 7(11):e976. PubMed ID: 37928625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of diffuse large B-cell lymphoma in a patient with Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma: clonal identity between two B-cell neoplasms.
    Shiseki M; Masuda A; Watanabe N; Fujii M; Kimura T; Yoshinaga K; Mori N; Teramura M; Motoji T
    Hematol Rep; 2011 Aug; 3(2):e10. PubMed ID: 22184531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of histological transformation events in Waldenström's macroglobulinemia (WM) and related disorders.
    Owen RG; Bynoe AG; Varghese A; de Tute RM; Rawstron AC
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):176-9. PubMed ID: 21856554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation and progression of Waldenström's macroglobulinemia following cladribine therapy in two cases: natural evolution or iatrogenic causation?
    Ling S; Joshua DE; Gibson J; Young G; Iland H; Watson G; Ho PJ
    Am J Hematol; 2006 Feb; 81(2):110-4. PubMed ID: 16432856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse large cell lymphoma occurring in a patient with Waldenström's macroglobulinemia. Evidence for the two different clones in Richter's syndrome.
    Chubachi A; Ohtani H; Sakuyama M; Nimura T; Mamiya S; Saitoh M; Watanuki T; Miura AB
    Cancer; 1991 Aug; 68(4):781-5. PubMed ID: 1906774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences.
    Kriangkum J; Taylor BJ; Treon SP; Mant MJ; Reiman T; Belch AR; Pilarski LM
    Clin Cancer Res; 2007 Apr; 13(7):2005-13. PubMed ID: 17404080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
    Morin RD; Assouline S; Alcaide M; Mohajeri A; Johnston RL; Chong L; Grewal J; Yu S; Fornika D; Bushell K; Nielsen TH; Petrogiannis-Haliotis T; Crump M; Tosikyan A; Grande BM; MacDonald D; Rousseau C; Bayat M; Sesques P; Froment R; Albuquerque M; Monczak Y; Oros KK; Greenwood C; Riazalhosseini Y; Arseneault M; Camlioglu E; Constantin A; Pan-Hammarstrom Q; Peng R; Mann KK; Johnson NA
    Clin Cancer Res; 2016 May; 22(9):2290-300. PubMed ID: 26647218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
    Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
    Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia.
    Castillo JJ; Gustine J; Meid K; Dubeau T; Hunter ZR; Treon SP
    Am J Hematol; 2016 Oct; 91(10):1032-5. PubMed ID: 27415417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse large B-cell lymphoma occurring in patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Clinicopathologic features of 12 cases.
    Lin P; Mansoor A; Bueso-Ramos C; Hao S; Lai R; Medeiros LJ
    Am J Clin Pathol; 2003 Aug; 120(2):246-53. PubMed ID: 12931555
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Poulain S; Roumier C; Bertrand E; Renneville A; Caillault-Venet A; Doye E; Geffroy S; Sebda S; Nibourel O; Nudel M; Herbaux C; Renaud L; Tomowiak C; Guidez S; Tricot S; Roche-Lestienne C; Quesnel B; Preudhomme C; Leleu X
    Clin Cancer Res; 2017 Oct; 23(20):6325-6335. PubMed ID: 28754818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.